Suppr超能文献

衰老与疾病中的烟酰胺腺嘌呤二核苷酸(NAD+)和沉默调节蛋白

NAD+ and sirtuins in aging and disease.

作者信息

Imai Shin-ichiro, Guarente Leonard

机构信息

Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Glenn Laboratory for the Science of Aging, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Trends Cell Biol. 2014 Aug;24(8):464-71. doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29.

Abstract

Nicotinamide adenine dinucleotide (NAD(+)) is a classical coenzyme mediating many redox reactions. NAD(+) also plays an important role in the regulation of NAD(+)-consuming enzymes, including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38/157 ectoenzymes. NAD(+) biosynthesis, particularly mediated by nicotinamide phosphoribosyltransferase (NAMPT), and SIRT1 function together to regulate metabolism and circadian rhythm. NAD(+) levels decline during the aging process and may be an Achilles' heel, causing defects in nuclear and mitochondrial functions and resulting in many age-associated pathologies. Restoring NAD(+) by supplementing NAD(+) intermediates can dramatically ameliorate these age-associated functional defects, counteracting many diseases of aging, including neurodegenerative diseases. Thus, the combination of sirtuin activation and NAD(+) intermediate supplementation may be an effective antiaging intervention, providing hope to aging societies worldwide.

摘要

烟酰胺腺嘌呤二核苷酸(NAD(+))是一种介导许多氧化还原反应的经典辅酶。NAD(+)在调控消耗NAD(+)的酶(包括沉默调节蛋白、聚ADP核糖聚合酶(PARP)和CD38/157外切酶)方面也发挥着重要作用。NAD(+)生物合成,特别是由烟酰胺磷酸核糖转移酶(NAMPT)介导的生物合成,与SIRT1功能共同调节代谢和昼夜节律。NAD(+)水平在衰老过程中下降,这可能是一个致命弱点,会导致核功能和线粒体功能缺陷,并引发许多与衰老相关的病理状况。通过补充NAD(+)中间体来恢复NAD(+)水平,可以显著改善这些与衰老相关的功能缺陷,对抗包括神经退行性疾病在内的许多衰老相关疾病。因此,激活沉默调节蛋白与补充NAD(+)中间体相结合可能是一种有效的抗衰老干预措施,为全球老龄化社会带来了希望。

相似文献

1
NAD+ and sirtuins in aging and disease.衰老与疾病中的烟酰胺腺嘌呤二核苷酸(NAD+)和沉默调节蛋白
Trends Cell Biol. 2014 Aug;24(8):464-71. doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29.
2
NAD Intermediates: The Biology and Therapeutic Potential of NMN and NR.NAD 中间体:NMN 和 NR 的生物学和治疗潜力。
Cell Metab. 2018 Mar 6;27(3):513-528. doi: 10.1016/j.cmet.2017.11.002. Epub 2017 Dec 14.
7
The balance between NAD biosynthesis and consumption in ageing.衰老过程中 NAD 生物合成与消耗的平衡。
Mech Ageing Dev. 2021 Oct;199:111569. doi: 10.1016/j.mad.2021.111569. Epub 2021 Sep 9.
10
Implications of NAD boosters in translational medicine.NAD 增强剂在转化医学中的意义。
Eur J Clin Invest. 2020 Oct;50(10):e13334. doi: 10.1111/eci.13334. Epub 2020 Jul 22.

引用本文的文献

4
Protein Acetylation and NAD+ Homeostasis in Aging Muscle.衰老肌肉中的蛋白质乙酰化与NAD+稳态
Adv Exp Med Biol. 2025;1478:421-443. doi: 10.1007/978-3-031-88361-3_17.
5
Cellular Models of Aging and Senescence.衰老与细胞衰老的细胞模型
Cells. 2025 Aug 18;14(16):1278. doi: 10.3390/cells14161278.
6
Roles of SIRT3 in aging and aging-related diseases.SIRT3在衰老及衰老相关疾病中的作用。
Int J Biol Sci. 2025 Jul 28;21(11):5135-5163. doi: 10.7150/ijbs.115518. eCollection 2025.

本文引用的文献

2
Circadian disruption in the pathogenesis of metabolic syndrome.昼夜节律紊乱在代谢综合征发病机制中的作用。
Diabetes Metab. 2014 Nov;40(5):338-46. doi: 10.1016/j.diabet.2013.12.005. Epub 2014 Jan 14.
4
SirT3 regulates the mitochondrial unfolded protein response.SirT3 调控线粒体未折叠蛋白反应。
Mol Cell Biol. 2014 Feb;34(4):699-710. doi: 10.1128/MCB.01337-13. Epub 2013 Dec 9.
5
Calorie restriction and sirtuins revisited.热量限制与 Sirtuins 再探。
Genes Dev. 2013 Oct 1;27(19):2072-85. doi: 10.1101/gad.227439.113.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验